MERIDIAN, ID -- (MARKET WIRE) -- 04/11/08 -- RxElite, Inc. (OTCBB: RXEI) is pleased toannounce the contract award from National Surgical Hospitals, for theiranesthetic gas products. RxElite was awarded a preferred contract listingfor all classes of trade for Sojourn(TM)(Sevoflurane) andTerrell(TM)(Isoflurane). Sevoflurane is most commonly used anesthetic gasin the U.S and Isoflurane continues to hold share in the anesthetic gasmarket."We are excited to partner with NSH. The agreement will yield significantcost saving to NSH members," stated Jonathan Houssian, the CEO of RxElite.
RxElite anesthetic gases are manufactured by MINRAD International, Inc.(AMEX: BUF), a leader in the innovation of anesthesia. RxElite holds theexclusive distribution rights for Minrad-produced anesthetic gases for thehuman market in the United States.
About RxElite, Inc.
RxElite, Inc. develops, manufactures, and markets generic prescription drugproducts in specialty generic markets. These markets include products inthe areas of anesthesia, sterile liquid dose drugs (including respiratoryinhalation drugs, ophthalmics, and injectable drugs), complex activepharmaceutical ingredients, and other specialty areas. www.RxElite.com
About MINRAD, International, Inc.
MINRAD International, Inc. is an interventional pain management companywith real-time image guidance and anesthesia and analgesia product lines,and also manufactures and markets generic inhalation anesthetics for use inconnection with human and veterinary surgical procedures. The company isdeveloping a drug/drug delivery system for conscious sedation, which,similar to nitrous oxide in dental surgery, provides a patient with painrelief without loss of consciousness. www.minrad.com
About National Surgical Hospitals
National Surgical Hospitals owns, operates, and develops surgical hospitalsand surgery centers in partnership with local physicians. It operates 11surgical hospitals in Arizona, Idaho, Michigan, New Mexico, North Carolina,Texas, Utah, and Wisconsin, with additional facilities scheduled to open inthe next 12 months in California, Colorado, and Wyoming. It also operatesseven orthopedic-focused surgery centers in Arizona, California, Michigan,and Texas. More information about NSH's innovative way to deliverhigh-quality surgical care is available at http://www.nshinc.com.
Safe Harbor Statement
This press release contains forward-looking statements within the meaningof the Private Securities Litigation Reform Act of 1995 involving known andunknown risks, delays, and uncertainties that may cause our actual resultsor performance to differ materially from those expressed or implied bythese forward-looking statements. These risks, delays, and uncertaintiesinclude, but are not limited to: risks associated with the uncertainty offuture financial results, our reliance on our sole supplier, the limiteddiversification of our product offerings, additional financingrequirements, development of new products, government approval processes,the impact of competitive products or pricing, technological changes, theeffect of economic conditions and other uncertainties detailed in theCompany's filings with the Securities and Exchange Commission. The Companyundertakes no obligation to update any forward-looking statements.
For more information:
Corporate Information
Ph: (208) 288-5550
Toll Free: (800) 414-1901
Fax: (208) 288-1191
Investor Relations
Ric Tener
Ph: (208) 288-5550
Fax: (208) 288-1191
Email: Email Contact
